Cargando…
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117801/ https://www.ncbi.nlm.nih.gov/pubmed/27727233 http://dx.doi.org/10.1038/bjc.2016.342 |
| _version_ | 1782468871752515584 |
|---|---|
| author | Dalgleish, Angus G Stebbing, Justin Adamson, Douglas J A Arif, Seema Safia Bidoli, Paolo Chang, David Cheeseman, Sue Diaz-Beveridge, Robert Fernandez-Martos, Carlos Glynne-Jones, Rob Granetto, Cristina Massuti, Bartomeu McAdam, Karen McDermott, Raymond Martín, Andrés J Muñoz Papamichael, Demetris Pazo-Cid, Roberto Vieitez, Jose M Zaniboni, Alberto Carroll, Kevin J Wagle, Shama Gaya, Andrew Mudan, Satvinder S |
| author_facet | Dalgleish, Angus G Stebbing, Justin Adamson, Douglas J A Arif, Seema Safia Bidoli, Paolo Chang, David Cheeseman, Sue Diaz-Beveridge, Robert Fernandez-Martos, Carlos Glynne-Jones, Rob Granetto, Cristina Massuti, Bartomeu McAdam, Karen McDermott, Raymond Martín, Andrés J Muñoz Papamichael, Demetris Pazo-Cid, Roberto Vieitez, Jose M Zaniboni, Alberto Carroll, Kevin J Wagle, Shama Gaya, Andrew Mudan, Satvinder S |
| author_sort | Dalgleish, Angus G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5117801 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-51178012016-12-17 Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer Dalgleish, Angus G Stebbing, Justin Adamson, Douglas J A Arif, Seema Safia Bidoli, Paolo Chang, David Cheeseman, Sue Diaz-Beveridge, Robert Fernandez-Martos, Carlos Glynne-Jones, Rob Granetto, Cristina Massuti, Bartomeu McAdam, Karen McDermott, Raymond Martín, Andrés J Muñoz Papamichael, Demetris Pazo-Cid, Roberto Vieitez, Jose M Zaniboni, Alberto Carroll, Kevin J Wagle, Shama Gaya, Andrew Mudan, Satvinder S Br J Cancer Corrigendum Nature Publishing Group 2016-10-25 2016-10-11 /pmc/articles/PMC5117801/ /pubmed/27727233 http://dx.doi.org/10.1038/bjc.2016.342 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| spellingShingle | Corrigendum Dalgleish, Angus G Stebbing, Justin Adamson, Douglas J A Arif, Seema Safia Bidoli, Paolo Chang, David Cheeseman, Sue Diaz-Beveridge, Robert Fernandez-Martos, Carlos Glynne-Jones, Rob Granetto, Cristina Massuti, Bartomeu McAdam, Karen McDermott, Raymond Martín, Andrés J Muñoz Papamichael, Demetris Pazo-Cid, Roberto Vieitez, Jose M Zaniboni, Alberto Carroll, Kevin J Wagle, Shama Gaya, Andrew Mudan, Satvinder S Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer |
| title | Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer |
| title_full | Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer |
| title_fullStr | Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer |
| title_full_unstemmed | Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer |
| title_short | Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer |
| title_sort | randomised, open-label, phase ii study of gemcitabine with and without imm-101 for advanced pancreatic cancer |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117801/ https://www.ncbi.nlm.nih.gov/pubmed/27727233 http://dx.doi.org/10.1038/bjc.2016.342 |
| work_keys_str_mv | AT dalgleishangusg randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT stebbingjustin randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT adamsondouglasja randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT arifseemasafia randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT bidolipaolo randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT changdavid randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT cheesemansue randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT diazbeveridgerobert randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT fernandezmartoscarlos randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT glynnejonesrob randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT granettocristina randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT massutibartomeu randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT mcadamkaren randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT mcdermottraymond randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT martinandresjmunoz randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT papamichaeldemetris randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT pazocidroberto randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT vieitezjosem randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT zanibonialberto randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT carrollkevinj randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT wagleshama randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT gayaandrew randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer AT mudansatvinders randomisedopenlabelphaseiistudyofgemcitabinewithandwithoutimm101foradvancedpancreaticcancer |